Members

The Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center is devoted to advancing pancreatic cancer therapies stemming from rational biological hypotheses, mechanistic investigation, human behavioral influence, community outreach, and early phase clinical trials. As a part of an NCI-designated Comprehensive Cancer, the Institute integrates both basic biological research, clinical medicine, populations science in this effort as well as substantial transdisciplinary research that bridges scientific areas.

At the core of this multidisciplinary Institute, our leaders strive to pull together these disparate sciences with a goal of spawning novel concepts with which to improve how pancreatic cancer patients are treated. The goals of the institute are to foster collaborative efforts amongst the disciplines and treat those with pancreatic cancer in the most advanced and comprehensive way possible. New discoveries are moved from the bench to bed side through the Institute’s pipeline.

Steering Committee

  • Igor Astaturov, MD, PhD

    Co-Director, Marvin & Concetta Greenberg Pancreatic Cancer Institute
    Associate Professor, Department of Hematology/Oncology

    View Profile

    Medical Oncology & Laboratory Research

    Research focuses on cancer metabolism and signaling, with an emphasis on the role of sterol biosynthesis regulation in pancreatic cancer cell growth and survival

  • Edna (Eti) Cukierman, PhD

    Co-Director, Marvin & Concetta Greenberg Pancreatic Cancer Institute
    Professor

    Co-Leader, Cancer Signaling and Epigenetics Program
    Co-Director, Immune Monitoring Facility
    Chair, Institutional Biosafety Committee

    View Profile

    Laboratory Research

    Research focuses on the tumor microenvironment, with an emphasis on cancer-associated fibroblastic cells, their extracellular matrix, function & how these partake in pancreatic cancer nutritional support, drug resistance, & immunosuppression

  • Sanjay S. Reddy, MD, FACS

    Co-Director, Marvin & Concetta Greenberg Pancreatic Cancer Institute
    Associate Professor, Department of Surgical Oncology
    Associate Program Director, Complex General Surgical Oncology Fellowship
    Collaborating Member, Molecular Therapeutics
    Attending Surgeon

    View Profile

    Surgical Oncology

    Practice focuses on vascular resectability and staging of pancreatic cancer as well as multimodality therapy for these patients

  • Efrat Dotan, MD

    Chief, Division of Gastrointestinal Medical Oncology
    Associate Professor, Department of Hematology/Oncology
    Associate Director, Hematology/Oncology Fellowship Training Program

    View Profile

    Medical Oncology

    Practice focuses on clinical trials testing novel therapies for pancreatic cancer patients and on care of older adults with cancer

  • Shannon Lynch, PhD, MPH

    Assistant Professor, Cancer Prevention and Control

    View Profile

    Laboratory Research

    Research focuses on intergration and analysis of complex, multilevel data resources in order to study how the neighborhood, or environment where a person lives, together with a person's behavior and biology, can impact cancer risk and cancer health disparities

  • Joshua E. Meyer, MD

    Vice Chair, Translational Research, Department of Radiation Oncology
    Associate Professor, Department of Radiation Oncology

    View Profile

    Radiation Oncology

    Practice focuses on novel modalities of radiotherapy in pancreatic cancer with the goal of increasing surgically-resectable cohorts and improving patient outcomes

Program Manager

  • Kate Whittington
    Kate Whittington

Key Members

Clinical Faculty Members